Ganglioside GI

Ganglioside GI is a lipid of Sphingolipids (SP) class. Ganglioside gi is associated with abnormalities such as HIV Infections, Amyotrophic Lateral Sclerosis, Neuritis, Motor, Motor Neuron Disease and athymia. The involved functions are known as Gene Expression, antigen binding, Protective Agents, Binding (Molecular Function) and response to hormone stimulus. Ganglioside gi often locates in Membrane, Body tissue, Mucous Membrane, integral to membrane and Virion. The associated genes with Ganglioside GI are Fusion Protein, synthetic peptide, CTBS gene, IL2 gene and CD4 gene. The related lipids are Sphingolipids, sialogangliosides, Membrane Lipids, ganglioside, Gx and polysialoganglioside. The related experimental models are Knock-out, Disease model, Experimental Autoimmune Encephalomyelitis, Rodent Model and Transgenic Model.

References related to abnormalities published in Others

PMID	Journal	Published Date	Author	Title
27806275	Biophys. J.	2016	Fricke N and Dimova R	GM1 Softens POPC Membranes and Induces the Formation of Micron-Sized Domains.
27806280	Biophys. J.	2016	Patel DS et al.	Influence of Ganglioside GM1 Concentration on Lipid Clustering and Membrane Properties and Curvature.
27006465	MBio	2016	Luo Y et al.	Interaction between Simian Virus 40 Major Capsid Protein VP1 and Cell Surface Ganglioside GM1 Triggers Vacuole Formation.
26338710	J. Biol. Chem.	2015	Sasaki N et al.	Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells.
26099170	J. Neurol. Sci.	2015	Schneider JS et al.	GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding.
25733521	Infect. Immun.	2015	De Chatterjee A et al.	The assembly of GM1 glycolipid- and cholesterol-enriched raft-like membrane microdomains is important for giardial encystation.
24685176	Neuron	2014	Hong S et al.	Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes.
24371137	J. Biol. Chem.	2014	Lundius EG et al.	GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability.
24068789	Neurology	2013	Moeller S et al.	Lack of association between autism and anti-GM1 ganglioside antibody.
23884419	J. Biol. Chem.	2013	Saslowsky DE et al.	Ganglioside GM1-mediated transcytosis of cholera toxin bypasses the retrograde pathway and depends on the structure of the ceramide domain.
23199590	J. Neurol. Sci.	2013	Schneider JS et al.	A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.
23111873	MBio	2012	Jobling MG et al.	A single native ganglioside GM1-binding site is sufficient for cholera toxin to bind to cells and complete the intoxication pathway.
22975326	Dev. Cell	2012	Chinnapen DJ et al.	Lipid sorting by ceramide structure from plasma membrane to ER for the cholera toxin receptor ganglioside GM1.
22824274	Biophys. J.	2012	Štefl M et al.	Dynamics and size of cross-linking-induced lipid nanodomains in model membranes.
22529395	Proc. Natl. Acad. Sci. U.S.A.	2012	Puryear WB et al.	HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells.
22128166	J. Biol. Chem.	2012	Ohto U et al.	Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.
22118676	Chem. Biol.	2011	Sanghera N et al.	Deciphering the molecular details for the binding of the prion protein to main ganglioside GM1 of neuronal membranes.
21820887	Biosens Bioelectron	2011	Zhang J and Zhou X	Novel 3-dimensional dendrimer platform for glycolipid microarray.
21788572	Diabetes	2011	Wu G et al.	Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression.
21723896	Neurochem. Int.	2011	Kreutz F et al.	Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action.
21693704	J. Biol. Chem.	2011	Huang SH et al.	Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3).
20546707	Brain Res.	2010	Zhang JZ et al.	Monosialotetrahexosy-1 ganglioside attenuates diabetes-enhanced brain damage after transient forebrain ischemia and suppresses phosphorylation of ERK1/2 in the rat brain.
20237277	J. Neurosci.	2010	Maglione V et al.	Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.
19917257	Mol. Cell	2009	Sano R et al.	GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis.
19118221	J. Cell. Sci.	2009	Ichikawa N et al.	Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth.
18695048	J. Cell Biol.	2008	Veracini L et al.	The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1.
18603643	J. Lipid Res.	2008	Chen Y et al.	Fluorescence-topographic NSOM directly visualizes peak-valley polarities of GM1/GM3 rafts in cell membrane fluctuations.
18212085	Infect. Immun.	2008	Wolf AA et al.	Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules.
18192361	Biophys. J.	2008	Frey SL et al.	Condensing and fluidizing effects of ganglioside GM1 on phospholipid films.
18032586	Mol. Biol. Cell	2008	Galvan C et al.	Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase.
17855525	J. Virol.	2007	Campanero-Rhodes MA et al.	N-glycolyl GM1 ganglioside as a receptor for simian virus 40.
17488728	J. Biol. Chem.	2007	Sakai H et al.	ABCA2 deficiency results in abnormal sphingolipid metabolism in mouse brain.
17428969	J. Neurosci.	2007	Susuki K et al.	Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.
17258703	Dev. Biol.	2007	Comiskey M and Warner CM	Spatio-temporal localization of membrane lipid rafts in mouse oocytes and cleaving preimplantation embryos.
17000721	Infect. Immun.	2006	Blanco LP and Dirita VJ	Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells.
16636068	J. Biol. Chem.	2006	Zhang Q et al.	Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts.
16306414	J. Neurosci.	2005	Wu G et al.	Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1.
16140785	J. Virol.	2005	Jolly C and Sattentau QJ	Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity.
15927491	Seizure	2005	Aykutlu E et al.	No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study.
15817684	Blood	2005	Paccani SR et al.	Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects.
15772422	J. Lipid Res.	2005	Nakagawa T et al.	C18:3-GM1a induces apoptosis in Neuro2a cells: enzymatic remodeling of fatty acyl chains of glycosphingolipids.
15557670	Infect. Immun.	2004	Gabel BR et al.	Lipid raft-mediated entry is not required for Chlamydia trachomatis infection of cultured epithelial cells.
15350219	Mol. Cell	2004	Tessitore A et al.	GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis.
15277677	Proc. Natl. Acad. Sci. U.S.A.	2004	Yuki N et al.	Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
15215248	J. Biol. Chem.	2004	Liu Y et al.	Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
15189866	Biophys. J.	2004	Miller CE et al.	Cholera toxin assault on lipid monolayers containing ganglioside GM1.
15145933	J. Biol. Chem.	2004	Nishio M et al.	Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells.
15039337	Infect. Immun.	2004	Alaniz ME et al.	Normally occurring human anti-GM1 immunoglobulin M antibodies and the immune response to bacteria.
15034144	Mol. Biol. Cell	2004	Wilson BS et al.	Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes.
14970224	J. Biol. Chem.	2004	Papini N et al.	The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions.
12941687	EMBO J.	2003	Tsai B et al.	Gangliosides are receptors for murine polyoma virus and SV40.
12642099	Virology	2003	Jeffree CE et al.	Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy.
12391328	Proc. Natl. Acad. Sci. U.S.A.	2002	Wong AP and Groves JT	Molecular topography imaging by intermembrane fluorescence resonance energy transfer.
12388556	J. Biol. Chem.	2002	Rabin SJ et al.	Gangliosides activate Trk receptors by inducing the release of neurotrophins.
12384415	Blood	2002	Ito M et al.	NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
12183587	Infect. Immun.	2002	Nachamkin I et al.	Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
11865037	J. Cell. Sci.	2002	Majoul I et al.	Differential expression of receptors for Shiga and Cholera toxin is regulated by the cell cycle.
11733581	J. Exp. Med.	2001	Martin M et al.	Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
11711493	Hypertension	2001	Gouni-Berthold I et al.	Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway.
11675488	Proc. Natl. Acad. Sci. U.S.A.	2001	Sugimoto Y et al.	Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells.
11606627	J. Neurosci.	2001	Rodriguez JA et al.	Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture.
11447291	Proc. Natl. Acad. Sci. U.S.A.	2001	Aman AT et al.	A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity.
11391009	Proc. Natl. Acad. Sci. U.S.A.	2001	Berghs S et al.	Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome.
11283076	J. Clin. Microbiol.	2001	Prendergast MM et al.	Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.
11171945	Proc. Natl. Acad. Sci. U.S.A.	2001	van Meer G	What sugar next? Dimerization of sphingolipid glycosyltransferases.
11159960	Infect. Immun.	2001	Schroeder TH et al.	Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells.
11034355
10942779	J. Biol. Chem.	2000	Wilkening G et al.	Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
10644786	J. Neurol. Neurosurg. Psychiatry	2000	Kuwabara S et al.	Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.
10406985	J. Neurol. Neurosurg. Psychiatry	1999	Kuwabara S et al.	Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody.
10377164	Infect. Immun.	1999	Prendergast MM et al.	Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome.
10225903	Infect. Immun.	1999	Schwerer B et al.	Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.
9971824	J. Virol.	1999	Fujioka N et al.	Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
9673245	Infect. Immun.	1998	Prendergast MM et al.	Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
9650959	J. Clin. Microbiol.	1998	Sack DA et al.	Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin.
9635755	Biophys. J.	1998	Hirai M and Takizawa T	Intensive extrusion and occlusion of water in ganglioside micelles with thermal reversibility.
9585412	J. Cell Biol.	1998	Harder T et al.	Lipid domain structure of the plasma membrane revealed by patching of membrane components.
9585411	J. Cell Biol.	1998	Wolf AA et al.	Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia.
9573028	Blood	1998	Ilangumaran S et al.	CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes.
9312075	J. Biol. Chem.	1997	Miyazaki H et al.	Expression cloning of rat cDNA encoding UDP-galactose:GD2 beta1,3-galactosyltransferase that determines the expression of GD1b/GM1/GA1.
9144230	Proc. Natl. Acad. Sci. U.S.A.	1997	Williams NA et al.	Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin.
9056621	Stroke	1997	Mohand-Said S et al.	Intravitreal injection of ganglioside GM1 after ischemia reduces retinal damage in rats.
8707962	J. Clin. Pathol.	1996	Finsterer J et al.	Anti-GM1 antibodies in polyneuropathies of unknown origin.
8623106	Stroke	1996	Grieco G et al.	Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside.
7852388	J. Biol. Chem.	1995	Ferrari G et al.	Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors.
8027366	J. Clin. Pathol.	1994	Bansal AS et al.	IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
1577868	J. Cell Biol.	1992	Doherty P et al.	Ganglioside modulation of neural cell adhesion molecule and N-cadherin-dependent neurite outgrowth.
1561655	Stroke	1992	Mayer SA and Pulsinelli WA	Failure of GM1 ganglioside to influence outcome in experimental focal ischemia.
1651376	J. Neurosci.	1991	Masco D et al.	Interaction of ganglioside GM1 with the B subunit of cholera toxin modulates growth and differentiation of neuroblastoma N18 cells.
2237955	Stroke	1990	Seren MS et al.	Protective effects of a monosialoganglioside derivative following transitory forebrain ischemia in rats.
2672425	Stroke	1989	Argentino C et al.	GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.
2728048	Stroke	1989	Urbanics R et al.	Effect of GM1 ganglioside after focal cerebral ischemia in halothane-anesthetized cats.
3066849	J. Neurol. Neurosurg. Psychiatry	1988	Hoffbrand BI et al.	Trial of ganglioside GM1 in acute stroke.
3400101	Stroke	1988	Komatsumoto S et al.	Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats.
3802083	Cancer Res.	1987	Gorelik E	Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
3810717	Stroke		Tanaka K et al.	Effect of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats.
6481302	J. Exp. Med.	1984	Mercurio AM et al.	Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation.
6615438	Biochem. J.	1983	Ghidoni R et al.	Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.
457774	J. Cell Biol.	1979	Joseph KC et al.	Endocytosis of cholera toxin in GERL-like structures of murine neuroblastoma cells pretreated with GM1 ganglioside. Cholera toxin internalization into Neuroblastoma GERL.
404410	J. Med. Genet.	1977	Ginsburg CM and Long CG	GM1 gangliosidosis type 1 in twins.
18241673	Clin. Biochem.	2008	Gu J et al.	Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
17915254	J. Neurol. Sci.	2008	Nobile-Orazio E et al.	How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
12740812	Chembiochem	2003	Antoine T et al.	Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli.
11578853	Brain Dev.	2001	Taniguchi M et al.	Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain.
7595635	J. Neurol. Sci.	1995	Matsumoto A et al.	Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons.
19560125	Carbohydr. Res.	2009	Komori T et al.	Study on systematizing the synthesis of the a-series ganglioside glycans GT1a, GD1a, and GM1 using the newly developed N-Troc-protected GM3 and GalN intermediates.
18077059	Neurobiol. Aging	2009	Zhang H et al.	Ganglioside GM1 binding the N-terminus of amyloid precursor protein.
10526194	J. Neurol. Sci.	1999	Yuki N et al.	Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile.
28499578	Biophys. Chem.	2017	Rondelli V et al.	Building a biomimetic membrane for neutron reflectivity investigation: Complexity, asymmetry and contrast.
28410623	Biophys. J.	2017	Cebecauer M et al.	Impact of GM1 on Membrane-Mediated Aggregation/Oligomerization of β-Amyloid: Unifying View.
28392211	J Clin Neurosci	2017	Su D et al.	Monosialotetrahexosy-1 ganglioside attenuates diabetes-associated cerebral ischemia/reperfusion injury through suppression of the endoplasmic reticulum stress-induced apoptosis.
27815022	Neuroscience	2017	Kasahara R et al.	The σ1 receptor regulates accumulation of GM1 ganglioside-enriched autophagosomes in astrocytes.
26259785	Biophys. Chem.	2016	Nicastro MC et al.	Amyloid β-peptide insertion in liposomes containing GM1-cholesterol domains.
26024958	Trends Biochem. Sci.	2015	Ledeen RW and Wu G	The multi-tasked life of GM1 ganglioside, a true factotum of nature.
26021803	Mol. Immunol.	2015	Phongsisay V et al.	Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors.
25600806	Biochem. Biophys. Res. Commun.	2015	Yamamoto N et al.	Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor.
25448159	Exp. Neurol.	2015	Hadaczek P et al.	GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.
25157033	J. Neurol. Neurosurg. Psychiatry	2015	Cats EA et al.	Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.
24524938	Colloids Surf B Biointerfaces	2014	Schulte W et al.	A Langmuir monolayer study of the action of phospholipase A2 on model phospholipid and mixed phospholipid-GM1 ganglioside membranes.
24273220	J. Neurol. Neurosurg. Psychiatry	2015	Mitsui Y et al.	A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes.
24231767	Mol. Immunol.	2014	Novák J et al.	GM1 controlled lateral segregation of tyrosine kinase Lck predispose T-cells to cell-derived galectin-1-induced apoptosis.
24229616	Lancet Neurol	2013	Kuwabara S and Yuki N	Axonal Guillain-Barré syndrome: concepts and controversies.
23907602	J. Neurol. Neurosurg. Psychiatry	2014	Nobile-Orazio E et al.	Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy.
23261829	Cell. Immunol.	2012	Bibolini MJ et al.	The hybrid between the ABC domains of synapsin and the B subunit of Escherichia coli heat-labile toxin ameliorates experimental autoimmune encephalomyelitis.
23138763	J. Neurol. Neurosurg. Psychiatry	2013	Kuwahara M et al.	Clinical features of CIDP with LM1-associated antibodies.
22883289	Pediatr. Neurol.	2012	Lee KY	Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis.
22634013	Biochem. Biophys. Res. Commun.	2012	Mrówczyńska L et al.	Spontaneous curvature of ganglioside GM1--effect of cross-linking.
22609227	Am. J. Pathol.	2012	Yang L et al.	Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis.
22450166	Dev. Comp. Immunol.	2012	Garcia-Garcia E et al.	Evidence for the presence of functional lipid rafts in immune cells of ectothermic organisms.
22397758	Biomed. Pharmacother.	2012	Chen XF et al.	The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study.
22071505	FASEB J.	2012	Bucciantini M et al.	Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1.
21820419	Biochem. Pharmacol.	2011	Rufini S et al.	The sterile alpha-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles.
21071752	J. Neurol. Neurosurg. Psychiatry	2011	Kuwabara S et al.	Neuromuscular transmission is not impaired in axonal Guillain--Barré syndrome.
21055402	Exp. Eye Res.	2011	Corley SC and Albert AD	Assessment of bovine rod outer segment disk membrane heterogeneity utilizing flow cytometry.
20667861	J. Neurol. Neurosurg. Psychiatry	2011	Yuki N et al.	IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
20659560	Mol. Cell. Neurosci.	2010	Ueda A et al.	Anti-GM1 antibodies affect the integrity of lipid rafts.
20581137	J. Neurol. Neurosurg. Psychiatry	2010	Pestronk A et al.	Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.
20211906	Neurology	2010	Sutedja NA et al.	Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy.
20206941	J. Neurol. Sci.	2010	Schneider JS et al.	GM1 ganglioside in Parkinson's disease: Results of a five year open study.
20171893	J Clin Neurosci	2010	Huang F et al.	GM1 and nerve growth factor modulate mitochondrial membrane potential and neurofilament light mRNA expression in cultured dorsal root ganglion and spinal cord neurons during excitotoxic glutamate exposure.
20114052	J. Mol. Biol.	2010	Di Pasquale E et al.	Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
19428361	Chem. Phys. Lipids	2009	Mikhalyov I et al.	Fluorescent BODIPY-labelled GM1 gangliosides designed for exploring lipid membrane properties and specific membrane-target interactions.
19200732	J Clin Neurosci	2009	Young JW et al.	Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies.
18835310	Neurochem. Int.	2008	Furian AF et al.	L-NAME prevents GM1 ganglioside-induced vasodilation in the rat brain.
18329889	Cytokine	2008	Vieira KP et al.	Ganglioside GM1 effects on the expression of nerve growth factor (NGF), Trk-A receptor, proinflammatory cytokines and on autoimmune diabetes onset in non-obese diabetic (NOD) mice.
18190792	Biochem. Biophys. Res. Commun.	2008	Takamura A et al.	Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis.
17697937	Free Radic. Biol. Med.	2007	Furian AF et al.	GM1 ganglioside induces vasodilation and increases catalase content in the brain.
17692296	Brain Res.	2007	Crain SM and Shen KF	Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
17582434	J. Mol. Biol.	2007	Okada T et al.	Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
17572397	Carbohydr. Res.	2007	Fujitani N et al.	Structural transition of a 15 amino acid residue peptide induced by GM1.
16962073	Biochem. Pharmacol.	2006	Gorria M et al.	Protective effect of monosialoganglioside GM1 against chemically induced apoptosis through targeting of mitochondrial function and iron transport.
16730958	Colloids Surf B Biointerfaces	2006	Weng KC et al.	Fluid supported lipid bilayers containing monosialoganglioside GM1: a QCM-D and FRAP study.
16516483	Neurobiol. Dis.	2006	Fighera MR et al.	GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole.
16343699	Vaccine	2006	Montaner AD et al.	Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route.
16213682	J Ethnopharmacol	2006	Chen JC et al.	Anti-diarrheal effect of Galla Chinensis on the Escherichia coli heat-labile enterotoxin and ganglioside interaction.
16154154	J. Neurol. Sci.	2005	Kuijf ML et al.	Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
16084500	Brain Res.	2005	Mo L et al.	GM1 and ERK signaling in the aged brain.
15925771	J Clin Neurosci	2005	Csurhes PA et al.	Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
15748609	Clin. Chim. Acta	2005	Sano R et al.	G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis.
15718041	Neurobiol. Aging	2005	Pitto M et al.	Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients.
15708506	Colloids Surf B Biointerfaces	2005	Miller CE et al.	Neutron and X-ray scattering studies of cholera toxin interactions with lipid monolayers at the air-liquid interface.
15194154	Microb. Pathog.	2004	Bhattacharyya S et al.	Effect of W07-toxin on gut physiological response in mice.
15013028	Eur Neuropsychopharmacol	2004	Perry JC et al.	Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
14672816	Brain Res.	2004	Crain SM and Shen KF	Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice.
14630342	Neurosci. Res.	2003	O'Hanlon GM et al.	Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay.
12770782	Biochimie		Sadeghlar F et al.	Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
12763482	Clin. Immunol.	2003	Wadehra M et al.	The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death.
12117481	Neuromuscul. Disord.	2002	Toscano A et al.	Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association.
11934394	Chem. Phys. Lipids	2002	Pei B et al.	Ganglioside GM(1) biphasically regulates the activity of protein kinase C by the effects on the structure of the lipid bilayer.
11825769	Microbes Infect.	2002	Nakano Y et al.	Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages.
11687226	Chem. Phys. Lipids	2001	Heywang C et al.	Interaction of GM(1) glycolipid in phospholipid monolayers with wheat germ agglutinin: effect of phospholipidic environment and subphase.
11357878	Int. Immunopharmacol.	2001	Nagai M and Masuzawa T	Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor.
11296965	J. Rheumatol.	2001	Werle E et al.	Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome.
11294921	Neurology	2001	Alaedini A and Latov N	A surface plasmon resonance biosensor assay for measurement of anti-GM(1) antibodies in neuropathy.
11274311	Neurology	2001	Hadden RD et al.	Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.
10980236	Brain Res.	2000	Goettl VM et al.	Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside.
10837887	Brain Res. Dev. Brain Res.	2000	Colella R et al.	GM1 enhances the association of neuron-specific MAP2 with actin in MAP2-transfected 3T3 cells.
10831769	J. Neurol. Sci.	2000	Odaka M et al.	Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
10708690	Brain Res.	2000	Goettl VM et al.	GM1 ganglioside restores abnormal responses to acute thermal and mechanical stimuli in aged rats.
10599811	Neurology	1999	Carpo M et al.	Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy.
10546847	Acta Trop.	1999	Cossy Isasi S et al.	GM1 ganglioside induced myocardial restoration and survival of mice with experimental Chagas' disease.
10407137	Brain Res. Dev. Brain Res.	1999	Kozireski-Chuback D et al.	Developmental appearance of nuclear GM1 in neurons of the central and peripheral nervous systems.
10331712	Neurology	1999	Dozier CE et al.	Diaphragmatic paralysis with monoclonal gammopathy and antiganglioside GM1 antibodies.
10188630	Gen. Pharmacol.	1999	Palermo-Neto J et al.	Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity.
9847018	Vet. Immunol. Immunopathol.	1998	Zhou J et al.	Evaluation of GM1 ganglioside-mediated apoptosis in feline thymocytes.
9783728	Biochem. Pharmacol.	1998	Thompson JP and Schengrund CL	Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of Escherichia coli to cell-surface GM1 by oligosaccharide-derivatized dendrimers.
9682887	Pediatr. Neurol.	1998	Hirai K et al.	Immunoadsorption therapy in Guillain-Barré syndrome.
9656423	Vet. Immunol. Immunopathol.	1998	Cox NR et al.	Thymic alterations in feline GM1 gangliosidosis.
9541741	Brain Res. Dev. Brain Res.	1998	Wang LJ et al.	Ganglioside GM1 alters neuronal morphology by modulating the association of MAP2 with microtubules and actin filaments.
9510073	Gen. Pharmacol.	1998	Hicks D et al.	Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia.
9367259	Brain Res.	1997	Heidinger V et al.	Peptide growth factors but not ganglioside protect against excitotoxicity in rat retinal neurons in vitro.
9335005	J. Neurol. Sci.	1997	Hirayama M et al.	Chorea-acanthocytosis with polyclonal antibodies to ganglioside GM1.
9117403	Brain Res.	1996	Dalia A et al.	Tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mesencephalic cultures after MPP+: the consequences of treatment with GM1 ganglioside.
8474009	J. Pharmacol. Exp. Ther.	1993	Simon RP et al.	GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
3925555	Science	1985	Alroy J et al.	Neurovisceral and skeletal GM1-gangliosidosis in dogs with beta-galactosidase deficiency.
824730	Science	1976	Read DH et al.	Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency.